idecabtagene vicleucel,lenalidomide
bms,2seventy bio
['mmsm', 'dance', 'karmma2', 'karmma']
 with a great presentation on concordance of ngs/ngf, serological response, and more impressive reapearance of normal pc as poor prognostic factors in karmma2 biomarker for loss of on-target, off-tumor effect? #ash22 #mmsm
| Hem/Onc fellow @WeillCornell | Interest in Plasma cell dyscrasias